MASH and Cardiovascular-Kidney-Metabolic Cross-Talk (R7)
March 6-9, 2028
| NTUH International Convention Center, Taipei, TPE, Taiwan
Bart Staels
| 4:00–8:00 PM | Registration |
| 6:00–8:00 PM | Welcome Mixer |
| 7:30–8:30 AM | Breakfast |
| 8:00–8:30 AM | Poster Setup |
| 8:15–5:00 PM | Poster Viewing |
| 8:30–8:40 AM | Welcome Remarks |
| 8:40–9:30 AM | Keynote Address |
| Arun J. Sanyal †, Virginia Commonwealth University Medical Center MASH as a Systemic Disease Across the Cardiovascular-Kidney-Metabolic Continuum |
| 9:30–11:45 AM | MASH as a Multisystem Disease - Whole-Patient Clinical Integration and Human Genetics |
| Alina M. Allen, Mayo Clinic The Liver in CKLM |
| Giovanni Targher †, University of Verona Whole-Patient Cardiovascular and Extra-hepatic Cancers in MASH |
| Katherine R. Tuttle †, University of Washington The Kidney in CKLM |
| Luca Lotta †, Regeneron Pharmaceuticals Inc. Human Genetics to Identify Shared Targets Across MASH and Cardiovascular-Kidney-Metabolic Disease |
| Short Talk(s) Chosen from Abstracts |
| 10:00–10:20 AM | Coffee Break |
| 11:45–12:45 PM | Lunch |
| 12:30–2:30 PM | Posters |
| 2:30–4:30 PM | Symposia Spotlight 1 |
| Short Talks Chosen from Abstracts |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | Mechanisms of Inter-Organ Crosstalk in MASH and CKLM |
| Jia-Horng Kao, National Taiwan University Infection Interaction with MASLD and CKLM Outcomes in Viral Hepatitis |
| Neil C. Henderson †, Institute of Regeneration and Repair, University of Edinburgh Shared Fibrotic Programs Across the Liver, Heart and Kidney in MASH |
| Yonglun Luo †, Aarhus University Endothelial Dysfunction as an Inter-Organ Mechanism in MASH and CKLM |
| Florian Kahles †, University Hospital RWTH Aachen Inflammation as a Unifying Mechanism in MASH and CKLM |
| Short Talk(s) Chosen from Abstracts |
| 7:00–8:00 PM | On Own for Dinner |
| 7:30–8:30 AM | Breakfast |
| 8:00–8:30 AM | Poster Setup |
| 8:15–5:00 PM | Poster Viewing |
| 8:30–11:30 AM | Metabolic and Cardio-Renal-Liver Axes in MASH |
| Lale Ozcan †, Columbia University The Liver in the Inter-Organ Cross-Talk from Pre-Diabetes to Diabetes |
| Kai-Chien Yang, National Taiwan University Liver Cross-Talk with the Cardiovascular System |
| Katalin Susztak †, University of Pennsylvania Liver-Kidney Cross-Talk in CKLM |
| Short Talk(s) Chosen from Abstracts |
| 9:30–9:50 AM | Coffee Break |
| 11:30–12:30 PM | Lunch |
| 12:30–2:30 PM | Posters |
| 3:00–4:30 PM | Career Roundtable |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | Gut-Liver-Adipose Signaling in MASH and CKLM |
| Susanne Mandrup †, University of Southern Denmark Liver-Adipose Tissue Cross-Talk Mechanisms |
| Rebecca A Haeusler †, Columbia University Liver-Intestine Communication in CKLM |
| Harry Sokol †, Saint-Antoine Hospital Gut Microbiota and Hepatic Inflammation in CKLM |
| Takahiro Ochiya †, Tokyo Medical University Hepatic Exosomes in CKLM |
| Short Talk(s) Chosen from Abstracts |
| 7:00–8:00 PM | On Own for Dinner |
| 7:30–8:30 AM | Breakfast |
| 8:30–11:30 AM | Human-Relevant Models, Multi-Omics, and AI for MASH Across Organ Systems |
| Vincent WS Wong †, Chinese University of Hong Kong Non-Invasive Tests to Assess Liver Dysfunction and Multi-Organ Failure in CKLM |
| Joseph C. Wu †, Stanford University Organoids / Organ-on-Chip: in vitro Modeling of Liver-Heart-Kidney Crosstalk |
| Karin Conde-Knape †, Valo Health AI to Accelerate Drug Development Acting on Multi-Organs in CKLM |
| Bart Staels, Institut Pasteur de Lille, Université Lille Experimental Models of Obesity, Metabolic Liver and Cardiovascular Disease |
| Short Talk(s) Chosen from Abstracts |
| 9:30–9:50 AM | Coffee Break |
| 11:40–12:40 PM | Meet-the-Editor |
| 12:40–5:00 PM | On Own for Lunch |
| 2:30–4:30 PM | Symposia Spotlight 2 |
| Short Talks Chosen from Abstracts |
| 4:30–5:00 PM | Coffee Available |
| 5:00–6:45 PM | Therapeutic Translation to Address Multi-Organ Disease in MASH and CKLM |
| Ruth E. Gimeno †, Eli Lilly and Company Role of Incretins in CKLM |
| Timothy P Rolph †, Akero Therapeutics FGF21 in CKLM |
| Rebecca A. Taub †, Madrigal Pharmaceuticals Targeting Thyroid Hormone Receptors in MASH with Impact on CKM |
| Lakshmi Santhanam †, Johns Hopkins University Tissue-Selective Drug Delivery |
| Short Talk(s) Chosen from Abstracts |
| 6:45–7:00 PM | Meeting Wrap-Up: Outcomes and Future Directions |
| 7:00–8:00 PM | Social Hour with Dinner |
| 8:00–11:00 PM | Cash Bar |
| 8:00–11:00 PM | Entertainment |
| 12:00–11:59 PM | Departure |